西安交通大学学报(医学版)
西安交通大學學報(醫學版)
서안교통대학학보(의학판)
JOURNAL OF XI'AN JIAOTONG UNIVERSITY(MEDICAL SCIENCES)
2010年
2期
208-211
,共4页
盛薇%车向明%单涛%樊林%李萌%张倩%高希涛
盛薇%車嚮明%單濤%樊林%李萌%張倩%高希濤
성미%차향명%단도%번림%리맹%장천%고희도
乳腺癌%c-erbB-2%免疫组织化学技术%荧光原位杂交技术
乳腺癌%c-erbB-2%免疫組織化學技術%熒光原位雜交技術
유선암%c-erbB-2%면역조직화학기술%형광원위잡교기술
breast cancer%c-erbB-2%immunohistochemistry%fluorescence in situ hybridization
目的 比较免疫组织化学法(IHC)和荧光原位杂交法(FISH)检测乳腺癌c-erbB-2状态的一致性.方法 选取乳腺癌石蜡标本共50例,其中以IHC法检测c-erbB-2蛋白表达(+)10例、(++)20例、(+++)20例.以FISH法检测上述乳腺癌细胞c-erbB-2基因扩增情况,分析比较两种方法差异性与相关性.结果 在IHC检测乳腺癌c-erbB-2(+)和(+++)时,FISH检测结果与其具有较好的一致性,总符合率为89.2%.在IHC检测c-erbB-2(++)时,FISH结果与其一致性较差,符合率仅为35.3%.结论 IHC可以作为初步筛查c-erbB-2表达的首选方法;IHC检测乳腺癌c-erbB-2(+)和(+++)时与FISH有良好的一致性.因IHC检测c-erbB-2表达(++)时与FISH结果的一致性较差,这类患者在应用赫赛汀治疗时应做FISH确诊.
目的 比較免疫組織化學法(IHC)和熒光原位雜交法(FISH)檢測乳腺癌c-erbB-2狀態的一緻性.方法 選取乳腺癌石蠟標本共50例,其中以IHC法檢測c-erbB-2蛋白錶達(+)10例、(++)20例、(+++)20例.以FISH法檢測上述乳腺癌細胞c-erbB-2基因擴增情況,分析比較兩種方法差異性與相關性.結果 在IHC檢測乳腺癌c-erbB-2(+)和(+++)時,FISH檢測結果與其具有較好的一緻性,總符閤率為89.2%.在IHC檢測c-erbB-2(++)時,FISH結果與其一緻性較差,符閤率僅為35.3%.結論 IHC可以作為初步篩查c-erbB-2錶達的首選方法;IHC檢測乳腺癌c-erbB-2(+)和(+++)時與FISH有良好的一緻性.因IHC檢測c-erbB-2錶達(++)時與FISH結果的一緻性較差,這類患者在應用赫賽汀治療時應做FISH確診.
목적 비교면역조직화학법(IHC)화형광원위잡교법(FISH)검측유선암c-erbB-2상태적일치성.방법 선취유선암석사표본공50례,기중이IHC법검측c-erbB-2단백표체(+)10례、(++)20례、(+++)20례.이FISH법검측상술유선암세포c-erbB-2기인확증정황,분석비교량충방법차이성여상관성.결과 재IHC검측유선암c-erbB-2(+)화(+++)시,FISH검측결과여기구유교호적일치성,총부합솔위89.2%.재IHC검측c-erbB-2(++)시,FISH결과여기일치성교차,부합솔부위35.3%.결론 IHC가이작위초보사사c-erbB-2표체적수선방법;IHC검측유선암c-erbB-2(+)화(+++)시여FISH유량호적일치성.인IHC검측c-erbB-2표체(++)시여FISH결과적일치성교차,저류환자재응용혁새정치료시응주FISH학진.
Objective To compare the consistency of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in detecting c-erbB-2 status in breast cancer tissues. Methods A total of 50 breast cancer paraffin embedded samples were selected, of which there were 10 cases of c-erbB-2 protein expression (+), 20 cases of (++) and 20 cases of (+++). FISH was used to assess the amplification of c-erbB-2 gene, and SPSS 13.0 software was employed to analyze the difference and consistency between the two methods. Results IHC and FISH methods had a good consistency when detecting c-erbB-2 (+) and (+++) expressions in breast cancer tissues, with the coincidence rate of 89.2%. However, when IHC was used to test c-erbB-2 (++), the result of FISH was quite different, with the coincidence rate of only 35.3%. Conclusion IHC is a preliminary method to detect c-erbB-2 status in breast cancer. IHC and FISH methods have a good consistency in detecting c-erbB-2 (+) and (+++) status in breast cancer tissues. As detection of c-erbB-2 (++) with IHC has a different result from FISH, such patients should receive FISH confirmation for herceptin therapy.